Back to User profile » Dr Darrell White
Papers published by Dr Darrell White:
Effect of Cyclosporine Ophthalmic Solution 0.09% on Signs and Symptoms of Dry Eye Disease in Patients Inadequately Controlled on Cyclosporine Ophthalmic Emulsion 0.05%: Results from a Single-Arm, Open-Label, Phase 4 Study
Johnston J, Adler R, Hessen M, Nichols KK, White D, Saenz B, Bowden F III, Periman LM, Truett K, Urbieta M, Mitchell B
Clinical Ophthalmology 2026, 20:583071
Published Date: 4 March 2026
Tear Film Hyperosmolarity is Associated with Increased Variation of Light Scatter Following Cataract Surgery
Sullivan BD, Palazón de la Torre M, Yago I, Duarte R, Schallhorn JM, Nijm LM, White DE, Berg MS, Artal P
Clinical Ophthalmology 2024, 18:2419-2426
Published Date: 28 August 2024
Physician Satisfaction with Anti-Inflammatory Topical Medications for the Treatment of Dry Eye Disease
White DE, Zhao Y, Jayapalan H, Machiraju P, Periyasamy R, Ogundele A
Clinical Ophthalmology 2020, 14:931-938
Published Date: 25 March 2020
Treatment Satisfaction Among Patients Using Anti-Inflammatory Topical Medications for Dry Eye Disease
White DE, Zhao Y, Jayapalan H, Machiraju P, Periyasamy R, Ogundele A
Clinical Ophthalmology 2020, 14:875-883
Published Date: 19 March 2020
Real-World Treatment Patterns Of Cyclosporine Ophthalmic Emulsion And Lifitegrast Ophthalmic Solution Among Patients With Dry Eye
White DE, Zhao Y, Ogundele A, Fulcher N, Acs A, Moore-Schiltz L, Karpecki PM
Clinical Ophthalmology 2019, 13:2285-2292
Published Date: 22 November 2019
Safety and efficacy of amniotic cytokine extract in the treatment of dry eye disease
Yeu E, Goldberg DF, Mah FS, Beckman KA, Luchs JI, Solomon JD, White DE, Gupta PK
Clinical Ophthalmology 2019, 13:887-894
Published Date: 27 May 2019